Human Growth Hormone Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The report covers Global Human Growth Hormone (HGH) Market Forecast & Analysis. The market is Segmented by Application (Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature, Prader-Willi Syndrome, and Other Applications), Distribution Channel (Hospitals and Retail Pharmacies, Online Pharmacies, and Other Distribution Channels), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The market values are provided in terms of (USD million) for the above segments.

Human Growth Hormone Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Human Growth Hormone Market Size

Human Growth Hormone (HGH) Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
CAGR 8.61 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration Low

Major Players

Human Growth Hormone (HGH) Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Global Human Growth Hormone (HGH) Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Human Growth Hormone Market Analysis

The Global Human Growth Hormone Market is expected to register a CAGR of 8.61% during the forecast period.

According to a research article by Mohamed Hamdy Elkarow et al., published in the Frontiers in Endocrinology Journal November 2020, patients with decreased growth hormone secretion constitute a risk factor for COVID-19 severity, which requires attention toward preventive measures in susceptible individuals.

In addition, patients with Prader-Willi syndrome should take extra precautions to minimize the risk of getting COVID-19. Moreover, Prader-Willi syndrome patients may not show typical symptoms such as a high temperature, and they may also experience a higher-than-normal pain threshold, which may delay the diagnosis of COVID-19.

The major factors driving the market growth include the development of recombinant human growth hormone drugs, rise in pituitary dysfunction cases, and rising off-label use of human growth hormones.

In humans, the growth hormone deficiency is caused when the pituitary gland does not synthesize enough concentration of human growth hormones. This deficiency is treated by administering recombinant human growth hormones by subcutaneous injection. Various genetic disorders such as Prader-Willi syndrome and Turner syndrome may also cause growth hormone deficiency, leading to delayed puberty and shorter-than-average height.

Turner syndrome, also known as congenital ovarian hypoplasia syndrome, occurs when the X chromosome is partially or completely missing in females. According to a research article by Xiaoxiao Cui et al., published in the Intractable & Rare Diseases Research Journal 2018, globally, Turner syndrome (TS) is a relatively common type of human chromosomal aberration that occurs in 1:2,500 live female births.

The human growth hormone helps to stimulate regeneration, reproduction, and growth. Rising use of growth hormones and awareness about growth hormones, which helps in the management of growth hormone deficiency disorders, are boosting the market growth.

Furthermore, most companies are investing in R&D to develop a growth hormone that has fewer side effects and will be a long-acting hormonal therapy. In addition, the rapid development of new novel recombinant human growth hormones is expected to drive the human growth hormone market over the forecast period.

Human Growth Hormone Industry Overview

The human growth hormone market is moderately consolidated, with a few market players controlling a significant market share. Furthermore, there are several active partnerships for the development of more efficacious and long-acting subtypes of human growth hormones. Some of the key market players include AnkeBio Co. Ltd, Eli Lilly and Company, Ferring BV, Novo Nordisk AS, Ipsen SA, Pfizer Inc., Genentech Inc. (Roche), and Teva Pharmaceutical Industries Ltd.

Human Growth Hormone Market Leaders

  1. AnkeBio Co. Ltd

  2. Eli Lilly and Company

  3. Ferring BV

  4. Novo Nordisk AS

  5. Ipsen S.A.

  6. *Disclaimer: Major Players sorted in no particular order
Human Growth Hormone (HGH) Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Human Growth Hormone Market News

In February 2021, Pfizer Inc. initiated a Phase III clinical trial to evaluate the efficacy and safety of somatropin in a cohort of Japanese participants with Prader-Willi Syndrome (PWS).

In October 2020, Erasmus Medical Center, in collaboration with Pfizer, Foundation for Prader-Willi Research, and Prader-Willi Fonds, initiated a Phase III clinical trial to assess the effect of growth hormone treatment (Genotropin) on physical and psychosocial health in adults of 30 years or older with Prader-Willi syndrome.

Human Growth Hormone Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Development of Recombinant Human Growth Hormone Drugs
    • 4.2.2 Rise in Pituitary Dysfunction Cases
    • 4.2.3 Rising Off-label Use of Human Growth Hormones
  • 4.3 Market Restraints
    • 4.3.1 Adverse Effects Associated with Human Growth Hormones
    • 4.3.2 Stringent Regulatory Processes
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1 By Application
    • 5.1.1 Growth Hormone Deficiency
    • 5.1.2 Turner Syndrome
    • 5.1.3 Idiopathic Short Stature
    • 5.1.4 Prader-Willi Syndrome
    • 5.1.5 Other Applications
  • 5.2 By Distribution Channel
    • 5.2.1 Hospitals and Retail Pharmacies
    • 5.2.2 Online Pharmacies
    • 5.2.3 Other Distribution Channels
  • 5.3 Geography
    • 5.3.1 North America
    • 5.3.1.1 United States (By Application and Distribution Channel)
    • 5.3.1.2 Canada (By Application and Distribution Channel)
    • 5.3.1.3 Mexico (By Application and Distribution Channel)
    • 5.3.2 Europe
    • 5.3.2.1 Germany (By Application and Distribution Channel)
    • 5.3.2.2 United Kingdom (By Application and Distribution Channel)
    • 5.3.2.3 France (By Application and Distribution Channel)
    • 5.3.2.4 Italy (By Application and Distribution Channel)
    • 5.3.2.5 Spain (By Application and Distribution Channel)
    • 5.3.2.6 Rest of Europe (By Application and Distribution Channel)
    • 5.3.3 Asia-Pacific
    • 5.3.3.1 China (By Application and Distribution Channel)
    • 5.3.3.2 Japan (By Application and Distribution Channel)
    • 5.3.3.3 India (By Application and Distribution Channel)
    • 5.3.3.4 Australia (By Application and Distribution Channel)
    • 5.3.3.5 South Korea (By Application and Distribution Channel)
    • 5.3.3.6 Rest of Asia-Pacific (By Application and Distribution Channel)
    • 5.3.4 Middle-East and Africa
    • 5.3.4.1 GCC (By Application and Distribution Channel)
    • 5.3.4.2 South Africa (By Application and Distribution Channel)
    • 5.3.4.3 Rest of Middle-East and Africa (By Application and Distribution Channel)
    • 5.3.5 South America
    • 5.3.5.1 Brazil (By Application and Distribution Channel)
    • 5.3.5.2 Argentina (By Application and Distribution Channel)
    • 5.3.5.3 Rest of South America (By Application and Distribution Channel)

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 AnkeBio Co. Ltd
    • 6.1.2 EMD Serono Inc.
    • 6.1.3 F.Hoffmann-La Roche Ltd
    • 6.1.4 Ferring BV
    • 6.1.5 Ipsen SA
    • 6.1.6 Eli Lilly and Company
    • 6.1.7 Novo Nordisk AS
    • 6.1.8 Pfizer Inc.
    • 6.1.9 Teva Pharmaceutical Industries Ltd
    • 6.1.10 Sandoz International GmbH (Novartis AG)
    • 6.1.11 Strongbridge Biopharma
    • 6.1.12 GeneScience Pharmaceuticals Co. Ltd
    • 6.1.13 Sinobioway Hygene Biomedicine Co. Ltd
    • 6.1.14 Aeterna Zentaris
    • 6.1.15 LG Life Sciences
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Human Growth Hormone Industry Segmentation

As per the scope of the report, the human growth hormone, also known as somatotropin, is a peptide hormone that stimulates growth, cell reproduction, and cell regeneration. The human growth hormone (HGH) market is segmented by application (growth hormone deficiency, Turner syndrome, idiopathic short stature, Prader-Willi syndrome, and other applications), distribution channel (hospitals and retail pharmacies, online pharmacies, and other distribution channels), and geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The report offers the value (in USD million) for the above segments.

By Application Growth Hormone Deficiency
Turner Syndrome
Idiopathic Short Stature
Prader-Willi Syndrome
Other Applications
By Distribution Channel Hospitals and Retail Pharmacies
Online Pharmacies
Other Distribution Channels
Geography North America United States (By Application and Distribution Channel)
Canada (By Application and Distribution Channel)
Mexico (By Application and Distribution Channel)
Europe Germany (By Application and Distribution Channel)
United Kingdom (By Application and Distribution Channel)
France (By Application and Distribution Channel)
Italy (By Application and Distribution Channel)
Spain (By Application and Distribution Channel)
Rest of Europe (By Application and Distribution Channel)
Asia-Pacific China (By Application and Distribution Channel)
Japan (By Application and Distribution Channel)
India (By Application and Distribution Channel)
Australia (By Application and Distribution Channel)
South Korea (By Application and Distribution Channel)
Rest of Asia-Pacific (By Application and Distribution Channel)
Middle-East and Africa GCC (By Application and Distribution Channel)
South Africa (By Application and Distribution Channel)
Rest of Middle-East and Africa (By Application and Distribution Channel)
South America Brazil (By Application and Distribution Channel)
Argentina (By Application and Distribution Channel)
Rest of South America (By Application and Distribution Channel)
Need A Different Region or Segment?
Customize Now

Human Growth Hormone Market Research FAQs

What is the current Global Human Growth Hormone (HGH) Market size?

The Global Human Growth Hormone (HGH) Market is projected to register a CAGR of 8.61% during the forecast period (2025-2030)

Who are the key players in Global Human Growth Hormone (HGH) Market?

AnkeBio Co. Ltd, Eli Lilly and Company, Ferring BV, Novo Nordisk AS and Ipsen S.A. are the major companies operating in the Global Human Growth Hormone (HGH) Market.

Which is the fastest growing region in Global Human Growth Hormone (HGH) Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Global Human Growth Hormone (HGH) Market?

In 2025, the North America accounts for the largest market share in Global Human Growth Hormone (HGH) Market.

What years does this Global Human Growth Hormone (HGH) Market cover?

The report covers the Global Human Growth Hormone (HGH) Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Global Human Growth Hormone (HGH) Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Growth Hormone Industry Report

Statistics for the 2025 Global Human Growth Hormone (HGH) market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Global Human Growth Hormone (HGH) analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.

Growth Hormone Market Report Snapshots